Home » Topics » BioWorld Science

BioWorld Science
RSS

Ostabaro approved in Japan for osteoporosis in patients at high risk of fractures

March 24, 2021

CVnCoV protects against SARS-CoV-2 B.1.351 variant in preclinical challenge study

March 24, 2021

FDA clears IND for phase I/II trial of EO-2463 for indolent NHL

March 24, 2021

ProQR plans phase II/III studies with QR-421a in Usher syndrome based on phase I/II trial analysis

March 24, 2021

LIBERTY randomized withdrawal study of relugolix combination therapy meets primary endpoint

March 24, 2021

Clover initiates phase II/III study of adjuvanted S-Trimer COVID-19 vaccine candidate

March 24, 2021

Phase II data for xanomeline/trospium as therapy for patients with schizophrenia

March 24, 2021

Kinase links innate immunity to MDS

March 24, 2021

GAUSS identifies subsets, improves UK Biobank interpretation

March 24, 2021

LINC-4 phase III data presented for osilodrostat in patients with Cushing's disease

March 24, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...